P. N. Hawkins Et Al. , "CANAKINUMAB PROVIDES RAPID IMPROVEMENT WITH SUSTAINED CLINICAL AND INFLAMMATORY REMISSION IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME PATIENTS ACROSS ALL SEVERITY PHENOTYPES," Annual Meeting of the British-Society-for-Rheumatology 2011 , vol.50, Brighton, United Kingdom, pp.53-54, 2011
Hawkins, P. N. Et Al. 2011. CANAKINUMAB PROVIDES RAPID IMPROVEMENT WITH SUSTAINED CLINICAL AND INFLAMMATORY REMISSION IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME PATIENTS ACROSS ALL SEVERITY PHENOTYPES. Annual Meeting of the British-Society-for-Rheumatology 2011 , (Brighton, United Kingdom), 53-54.
Hawkins, P. N., Kuemmerle-Deschner, J. B., Hachulla, E., Cartwright, R., Kone-Paut, I., Hoyer, J., ... Quartier, P.(2011). CANAKINUMAB PROVIDES RAPID IMPROVEMENT WITH SUSTAINED CLINICAL AND INFLAMMATORY REMISSION IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME PATIENTS ACROSS ALL SEVERITY PHENOTYPES . Annual Meeting of the British-Society-for-Rheumatology 2011 (pp.53-54). Brighton, United Kingdom
Hawkins, P. Et Al. "CANAKINUMAB PROVIDES RAPID IMPROVEMENT WITH SUSTAINED CLINICAL AND INFLAMMATORY REMISSION IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME PATIENTS ACROSS ALL SEVERITY PHENOTYPES," Annual Meeting of the British-Society-for-Rheumatology 2011, Brighton, United Kingdom, 2011
Hawkins, P. N. Et Al. "CANAKINUMAB PROVIDES RAPID IMPROVEMENT WITH SUSTAINED CLINICAL AND INFLAMMATORY REMISSION IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME PATIENTS ACROSS ALL SEVERITY PHENOTYPES." Annual Meeting of the British-Society-for-Rheumatology 2011 , Brighton, United Kingdom, pp.53-54, 2011
Hawkins, P. N. Et Al. (2011) . "CANAKINUMAB PROVIDES RAPID IMPROVEMENT WITH SUSTAINED CLINICAL AND INFLAMMATORY REMISSION IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME PATIENTS ACROSS ALL SEVERITY PHENOTYPES." Annual Meeting of the British-Society-for-Rheumatology 2011 , Brighton, United Kingdom, pp.53-54.
@conferencepaper{conferencepaper, author={P. N. Hawkins Et Al. }, title={CANAKINUMAB PROVIDES RAPID IMPROVEMENT WITH SUSTAINED CLINICAL AND INFLAMMATORY REMISSION IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME PATIENTS ACROSS ALL SEVERITY PHENOTYPES}, congress name={Annual Meeting of the British-Society-for-Rheumatology 2011}, city={Brighton}, country={United Kingdom}, year={2011}, pages={53-54} }